Performance Evaluation Of M&A Based On Balanced Score Card

In an increasingly competitive market environment,in order to maintain competitiveness,companies must expand their scale and enhance their strength.In view of factors such as investment cost and risk,M&A has become the preferred development mode for enterprises.M&A has become an important topic in researching corporate development strategies.However,countless failures show that the key to determining the success or failure of a merger is whether or not it is effectively integrated after the merger.Therefore,people are paying more and more attention to the integration of the two parties after the merger,paying attention to the evaluation of M&A performance.There are many ways to evaluate the performance of M&A.The choice of different methods affects the results of M&A performance to a certain extent.Based on the strategic performance management thinking and M&A theory,this paper uses the strategic performance evaluation tool to balance the scorecard to evaluate the performance of Anke Bio-M&A Soho.Different from the traditional performance evaluation method,the balanced scorecard not only pays attention to the change of the financial dimension,but also pays attention to the M&A performance from the overall perspective and joins the non-financial indicators.Evaluate from four dimensions.This paper is divided into five chapters.The first chapter is the introduction part,which mainly introduces the research significance,the research status at home and abroad and the overall thinking.The second chapter mainly introduces the theory and method of enterprise M&A performance evaluation,and focuses on the balanced scorecard theory.The third chapter is mainly based on the construction of the M&A performance evaluation index system based on the balanced scorecard.The fourth chapter is the case part of this paper.The fifth chapter sunmmarizes the case experience,points out limitations and gives countermeasures.Through such content arrangement,it is possible to clearly evaluate whether the acquisition performance of Anke Bio is in line with the purpose and development strategy of its merger,and also provide a new idea for performance evaluation for other companies that want to acquire.This paper selects the relevant data from 2013 to 2017,and conducts M&A performance evaluation on Anke Bio from four aspects:finance,customer,internal process,learning and growth.In terms of finance,Anke Bio's profitability indicators have generally increased,indicating that mergers and acquisitions have enhanced the company's profitability.The overall decline in operational capability indicators indicates that the company's inventory,accounts receivable and total asset turnover were affected due to the expansion of asset scale,sales scale expansion and management team expansion.In terms of solvency,although the solvency has declined,the use of funds is more efficient,and the indicator value is more reasonable.Growth capacity indicators have risen,indicating an increase in sustainability.In terms of customers,Anke Bio has joined forces with Suhao Yiming through the acquisition of Suhao Yiming,and the market share and brand attention have been improved after the merger.In terms of internal processes,when the merger and acquisition ended,the management capability indicator showed a decline,but as the merger and acquisition integration progressed,it improved.In terms of learning and growth,Anke Bio's high-end talents and R&D investment are constantly rising,indicating that learning and growth capabilities are enhanced.In general,Anke Bio basically achieved the strategic goal of M&A.